MKI67 and neoplasm: The potential technical limitations of automated analysis of Ki-67 PI are: a requirement for in-house validation of the method against manual cell count; counting a sufficient number of tumor cells to avoid misrepresentation of Ki-67 from intra-tumoral variability; and methods to exclude counting on non-tumor mitotic activity.